US EditionPublished • loading... • Updated
Epicrispr Biotechnologies Renews 25,000 SQFT at 7000 Shoreline Court in South San Francisco
Summary by The Registry
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Epicrispr Biotechnologies Renews 25,000 SQFT at 7000 Shoreline Court in South San Francisco
The epigenetic medicine company anchors its Peninsula headquarters as the Bay Area life sciences market navigates a gradual recovery. Epicrispr Biotechnologies, the CRISPR-pioneer-founded epigenetic medicine company known commercially as Epic Bio, renewed its 24,780-square-foot lease at 7000 Shoreline Court in South San Francisco during the first quarter of 2026, according to CBRE’s Q1 2026 San […] The post Epicrispr Biotechnologies Renews 25,00…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
